ThreeD Capital Acquires Additional Shares in Avicanna
Deal News | Mar 22, 2025 | Globenewswire
ThreeD Capital Inc. has issued an early warning report following recent acquisitions of Avicanna Inc. securities. A venture capital firm operating out of Toronto, ThreeD conducted a series of transactions to acquire 106,000 common shares of Avicanna Inc., increasing its stake marginally to approximately 17.4%, with an option for further partial dilution raising their potential stake to around 19.1%. The acquisitions, executed on the Toronto Stock Exchange, cost $37,400. ThreeD's investment strategy focuses on early-stage opportunities across junior resources and disruptive technology sectors, reflecting this buy as an affirmation of market conditions and strategic positioning. ThreeD, alongside Sheldon Inwentash, known as a Joint Actor, now controls a significant portion of Avicanna's common shares. The acquired shares underscore ThreeD's commitment to augmenting its investment in Avicanna, with possible future adjustments based on evolving market dynamics.
Sectors
- Venture Capital
- Technology
- Healthcare
Geography
- Canada – ThreeD Capital Inc. is a Canadian-based firm, with activities and transactions taking place within Canadian markets such as the Toronto Stock Exchange.
Industry
- Venture Capital – ThreeD Capital is involved in venture capital investments, strategically targeting companies in emerging industries such as junior resources and disruptive technologies.
- Technology – The article mentions disruptive technologies as a focus area for ThreeD Capital's investments, indicating a commitment to investing in innovative tech sectors.
- Healthcare – Avicanna Inc., as a target company, is involved in the healthcare industry, dealing with cannabis-based health solutions.
Financials
- $37,400 – Total consideration for acquiring 106,000 common shares of Avicanna Inc. at approximately $0.353 per share.
Participants
Name | Role | Type | Description |
---|---|---|---|
ThreeD Capital Inc. | Acquirer | Company | A Canadian venture capital firm focused on investments in junior resource and disruptive technology sectors. |
Avicanna Inc. | Target Company | Company | A company specializing in cannabis-based pharmaceutical and consumer products. |
Sheldon Inwentash | Investor | Person | A Joint Actor with ThreeD Capital, involved in the acquisition and investment strategy. |